Prestige Consumer Healthcare (PBH) Earnings Date, Estimates & Call Transcripts $83.71 +1.04 (+1.26%) (As of 12:50 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Prestige Consumer Healthcare Latest Earnings SummaryUpcoming Q3 Earnings DateFeb. 13EstimatedActual EPS (Nov. 7) $1.09 Consensus EPS (Nov. 7) $1.09 Prestige Consumer Healthcare announced Q2 2025 earnings on November 7, 2024, reporting an EPS of $1.09, which hit the consensus estimate of $1.09. Quarterly revenue fell .9% year-over-year to $283.79 million, above analyst estimates of $282.09 million. With a trailing EPS of $4.11 and a P/E Ratio of 20.37, Prestige Consumer Healthcare's earnings are expected to grow 6.74% next year, from $4.45 to $4.75 per share. Conference Call TranscriptConference Call AudioEarnings Press ReleaseEarnings Slide DeckSEC 10-Q/10-K FilingPBH Upcoming EarningsPrestige Consumer Healthcare's next earnings date is estimated for Thursday, February 13, 2025, based off prior year's reporting schedules. Get Prestige Consumer Healthcare Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Prestige Consumer Healthcare and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataPBH Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PBH Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad WealthPressBreaking News: Tesla headed to $500…That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. Prestige Consumer Healthcare Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20244$1.00$1.09$1.04 Q2 20245$1.06$1.11$1.08 Q3 20245$1.04$1.13$1.08 Q4 20245$1.10$1.14$1.13 FY 202419$4.20$4.47$4.32 Q1 20253$0.86$0.86$0.86 Q2 20253$1.08$1.09$1.08 Q3 20253$1.16$1.21$1.19 Q4 20252$1.24$1.24$1.24 FY 202511$4.34$4.40$4.37 Q1 20261$1.10$1.10$1.10 Q2 20261$1.18$1.18$1.18 Q3 20261$1.21$1.21$1.21 Q4 20261$1.23$1.23$1.23 FY 20264$4.72$4.72$4.72 Q1 20271$1.20$1.20$1.20 Prestige Consumer Healthcare Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 2/13/2025(Estimated)------- 11/7/2024Q2 2025$1.09$1.09-$1.09$282.09M$283.79M 8/8/2024Q1 2025$0.86$0.90+$0.04$0.82$260.54M$267.10M 5/14/2024Q4 2024$1.14$1.02 -$0.12$1.06$287.42M$277.00M 2/8/2024Q4 2023$1.04$1.06+$0.02$1.06$280.25M$282.74M 11/2/2023Q2 2024$1.07$1.07-$1.07$285.13M$286.32M8/3/2023Q2 2023$1.01$1.06+$0.05$1.06$278.79M$279.31M Tesla Execs are Freaking Out (Ad)It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.Click here to get the details.5/4/2023Q4 2023$1.04$1.07+$0.03$6.97$280.58M$285.90M 2/2/2023Q3 2023$1.01$1.04+$0.03$1.04$273.84M$275.50M Prestige Consumer Healthcare Earnings - Frequently Asked Questions When is Prestige Consumer Healthcare's earnings date? Prestige Consumer Healthcare has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 13th, 2025 based off last year's report dates. Learn more on PBH's earnings history. What guidance has Prestige Consumer Healthcare issued on next quarter's earnings? Prestige Consumer Healthcare issued an update on its FY25 earnings guidance on Thursday, November, 7th. The company provided EPS guidance of $4.40 to $4.46 for the period, compared to the consensus estimate of $4.42. The company issued revenue guidance of $1.125 billion to $1.140 billion, compared to the consensus revenue estimate of $1.13 billion. Did Prestige Consumer Healthcare beat their earnings estimates last quarter? In the previous quarter, Prestige Consumer Healthcare (NYSE:PBH) reported $1.09 earnings per share (EPS) to hit the analysts' consensus estimate of $1.09. Learn more on analysts' earnings estimate vs. PBH's actual earnings. How can I listen to Prestige Consumer Healthcare's earnings conference call? The conference call for Prestige Consumer Healthcare's latest earnings report can be listened to online. Listen to Conference Call How can I read Prestige Consumer Healthcare's conference call transcript? The conference call transcript for Prestige Consumer Healthcare's latest earnings report can be read online. Read Transcript How can I view Prestige Consumer Healthcare's earnings report? Prestige Consumer Healthcare's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Prestige Consumer Healthcare generate each year? Prestige Consumer Healthcare (NYSE:PBH) has a recorded annual revenue of $1.11 billion. How much profit does Prestige Consumer Healthcare generate each year? Prestige Consumer Healthcare (NYSE:PBH) has a recorded net income of $209.34 million. PBH has generated $4.11 earnings per share over the last four quarters. What is Prestige Consumer Healthcare's price-to-earnings ratio? Prestige Consumer Healthcare (NYSE:PBH) has a trailing price-to-earnings ratio of 20.37 and a forward price-to-earnings ratio of 18.81. The price/earnings-to-growth ratio is 2.32. What is Prestige Consumer Healthcare's EPS forecast for next year? Prestige Consumer Healthcare's earnings are expected to grow from $4.45 per share to $4.75 per share in the next year, which is a 6.74% increase. ` More Earnings Resources from MarketBeat Related Companies IPAR Earnings Date HLF Earnings Date USNA Earnings Date NUS Earnings Date NATR Earnings Date MED Earnings Date VERU Earnings Date EL Earnings Date UTHR Earnings Date VTRS Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report Breaking News: Tesla headed to $500… (Ad)That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. This page (NYSE:PBH) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prestige Consumer Healthcare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Prestige Consumer Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
